Overview

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to examine effects of fosbretabulin tromethamine (fosbretabulin) on PCV as reflected by a change from baseline in the number of polypoid lesions on indocyanine green angiography (ICGA).
Phase:
Phase 2
Details
Lead Sponsor:
Mateon Therapeutics
Treatments:
Combretastatin
Fosbretabulin